sleep-apnea
(2)
David Weber
David Weber, PhD, is the President and CEO of Mosanna Therapeutics, a Redwood City biotech developing MOS118, a bedtime nasal spray for obstructive sleep apnea that aims to restore the body's natural airway reflex during sleep. A biotech operator with more than 30 years in drug development, capital formation, and corporate strategy, he previously led Otonomy through its IPO and multiple clinical programs, and served as CEO of MacuSight and Oculex Pharmaceuticals. He joined Mosanna in June 2025 as the company launched with an $80 million Series A.
Joe Megibow
Joe Megibow is a serial CEO and digital commerce veteran who has led some of the most recognizable consumer brands in sleep — from Purple Innovation and Casper Sleep to cpap.com — building a career defined by turning legacy industries on their heads through e-commerce, omnichannel strategy, and relentless operational focus. With stops at Expedia, American Eagle Outfitters, and a handful of successful exits along the way, Megibow brings three decades of digital disruption experience to every seat at the table.